Efficacy and safety of Ferric carboxymaltose injection compared with oral iron for the treatment of postpartum anemia in Japan: a randomized controlled clinical trial
Not Applicable
- Conditions
- postpartum anemia
- Registration Number
- JPRN-UMIN000046049
- Lead Sponsor
- Jikei university school of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients whose CRP level measured exceeds 20 mg/L (2) Patients with hematological diseases (3) Patients with serious hepatic disorder, renal disorder, or cardiovascular disease 4) Persons who have received a blood transfusion within 1 week (5) Patients with malignant tumors (6) Patients with a history of serious drug allergy such as anaphylactic shock or a history of serious adverse drug reactions.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in Hb level after 2 weeks of treatment
- Secondary Outcome Measures
Name Time Method